Although [11C]-PBR28 is known to have a better signal-to-noise ratio and pharmacokinetic properties, compared to the first-generation TSPO tracer [11C]-R-PK11195, its use in longitudinal studies of AD is limited by several factors [4]. The gene discussed is TSPO; the disease is Alzheimer disease.